Clinical Trials Browser

Phase 3 × Desmoid Tumors × Sorafenib × Clear all

NCT02066181 2023-06-07

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Phase 3 Completed

87 enrolled 14 charts

Desmoid Tumors